FDA Analysis: Weight Loss Supplement Contains Unapproved Medication

FDA Analysis: Weight Loss Supplement Contains Unapproved Medication
November 26, 2014

A laboratory analysis found an unapproved medication in a weight loss supplement.

Slim Vie contains sibutramine, a controlled substance that was removed from the market in 2010 for safety reasons.

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Slim Vie, a product promoted and sold for weight loss on various websites, and possibly in some retail stores.

The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

The FDA issued the notification to address a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being all natural. The FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories.